CEL SCI CORP (CVM) Insider Trading Disclosures
CEL SCI CORP (CVM) is a publicly traded company on the NYSE, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CVM
CIK: 725363
Exchange: NYSE
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 09/30
State: CO
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 9/30/2023 12:00:00 AM
Lead Engagement PartnerRobert Garcia
Audit LocationPotomac, Maryland, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-01 | 2026-09-30 | PRIMARY DOCUMENT | 0001238028-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | PRIMARY DOCUMENT | 0001236215-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | PRIMARY DOCUMENT | 0001236030-26-000009 | View SEC Doc Filr Page |
| S-8 | 2026-09-03 | — | FORM S-8 | 0001654954-26-008115 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-25 | PRIMARY DOCUMENT | 0001236030-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-14 | PRIMARY DOCUMENT | 0001511858-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-14 | PRIMARY DOCUMENT | 0001646989-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-14 | PRIMARY DOCUMENT | 0001282304-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-14 | PRIMARY DOCUMENT | 0001238028-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-14 | PRIMARY DOCUMENT | 0001236215-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-14 | PRIMARY DOCUMENT | 0001236030-26-000007 | View SEC Doc Filr Page |
| 8-K | 2026-08-17 | 2026-08-14 | FORM 8-K | 0001654954-26-007691 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | FORM 10-Q | 0001654954-26-007657 | View SEC Doc Filr Page |
| ARS | 2026-07-02 | 2025-09-30 | ARS | 0001654954-26-006497 | View SEC Doc Filr Page |
| DEF 14A | 2026-07-02 | 2026-06-23 | DEF 14A | 0001654954-26-006496 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | PRIMARY DOCUMENT | 0001238028-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | PRIMARY DOCUMENT | 0001236215-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | PRIMARY DOCUMENT | 0001236030-26-000006 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-14 | FORM 8-K | 0001654954-26-006015 | View SEC Doc Filr Page |
| 424B5 | 2026-06-15 | — | FORM 424B5 | 0001654954-26-005987 | View SEC Doc Filr Page |
| RW | 2026-05-27 | — | FORM RW | 0001654954-26-005431 | View SEC Doc Filr Page |
| RW | 2026-05-19 | — | FORM RW | 0001654954-26-005074 | View SEC Doc Filr Page |
| 4 | 2026-05-18 | 2026-05-14 | PRIMARY DOCUMENT | 0001236030-26-000005 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | FORM 10-Q | 0001654954-26-005005 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-11 | FORM 8-K | 0001654954-26-004910 | View SEC Doc Filr Page |